What AI says about Nanoscope Therapeutics

Nanoscope Therapeutics is a biotechnology company developing a new generation of optogenetic therapy designed to restore vision lost to retinal degeneration. Its MCO 010 platform is the first broad-spectrum, fast-response optogenetic technology that has demonstrated vision restoration in clinical trials for patients with severe vision loss.

AI named Nanoscope Therapeutics from January 2026 to March 2026.